Standard Biotools Inc.
LAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001162194
No open-market purchases or sales by Standard Biotools Inc. insiders were filed in the last 90 days; 143 institutions reported holding it in 13F filings for Q2 2026, worth $243.6M in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q4 2021
Institutional positions in Standard Biotools Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 121
- +3 vs. Q3 2021
- Shares held
- 56.3M
- −2.16M (−3.7%) vs. Q3 2021
- Total value
- $220.4M
- −$164.9M (−42.8%) vs. Q3 2021
- New holders
- 22
- 33 more added
- Sold out
- 19
- 44 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 143 | $243.6M |
| Q1 2026 | 156 | $273.4M |
| Q4 2025 | 159 | $387.4M |
| Q3 2025 | 155 | $371.5M |
| Q2 2025 | 160 | $336.6M |
| Q1 2025 | 145 | $304.1M |
| Q4 2024 | 142 | $487.1M |
| Q3 2024 | 141 | $542.6M |
| Q2 2024 | 145 | $480.1M |
| Q1 2024 | 145 | $719.0M |
| Q4 2023 | 86 | $107.4M |
| Q3 2023 | 72 | $137.5M |
| Q2 2023 | 66 | $89.1M |
| Q1 2023 | 69 | $89.9M |
| Q4 2022 | 68 | $54.4M |
| Q3 2022 | 65 | $42.5M |
| Q2 2022 | 86 | $70.2M |
| Q1 2022 | 109 | $179.5M |
| Q4 2021 | 121 | $220.4M |
| Q3 2021 | 119 | $386.6M |
| Q2 2021 | 113 | $354.4M |
| Q1 2021 | 138 | $268.7M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Standard Biotools Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Millennium Management LLC | 594,005 | $2.33M | 0.00% | −2,258,509−79.2% | Reduced |
| Balyasny Asset Management LLC | 700,000 | $2.74M | 0.01% | +381,009+119.4% | Added |
| UBS Group AG | 725,165 | $2.84M | 0.00% | −62,997−8.0% | Reduced |
| Paradigm Capital Management Inc | 771,100 | $3.02M | 0.14% | −144,900−15.8% | Reduced |
| Northern Trust Corp | 772,379 | $3.03M | 0.00% | +15,631+2.1% | Added |
| D. E. Shaw & Co., Inc. | 891,635 | $3.50M | 0.00% | +102,428+13.0% | Added |
| PFM Health Sciences, LP | 980,505 | $3.84M | 0.13% | 00.0% | Unchanged |
| Repertoire Partners LP | 1,000,000 | $3.92M | 3.24% | +1,000,000 | New |
| Dimensional Fund Advisors LP | 1,046,513 | $4.10M | 0.00% | +94,656+9.9% | Added |
| Tikvah Management LLC | 1,250,000 | $4.90M | 1.37% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,375,762 | $5.39M | 0.00% | +26,003+1.9% | Added |
| State Street Corp | 1,467,061 | $5.75M | 0.00% | +14,779+1.0% | Added |
| Nuveen Asset Management, LLC | 1,955,086 | $7.66M | 0.00% | +23,251+1.2% | Added |
| Boothbay Fund Management, LLC | 2,302,278 | $9.03M | 0.30% | 00.0% | Unchanged |
| Needham Investment Management LLC | 3,515,000 | $13.8M | 1.73% | +225,000+6.8% | Added |
| OrbiMed Advisors LLC | 3,819,348 | $15.0M | 0.19% | −780,223−17.0% | Reduced |
| Vanguard Group Inc | 3,867,671 | $15.2M | 0.00% | +280,792+7.8% | Added |
| Neuberger Berman Group LLC | 4,195,687 | $16.2M | 0.01% | −84,503−2.0% | Reduced |
| Primecap Management Co | 5,093,403 | $20.0M | 0.01% | −169,640−3.2% | Reduced |
| BlackRock Inc. | 6,251,230 | $24.5M | 0.00% | −99,499−1.6% | Reduced |
| Indaba Capital Management, L.P. | 7,446,229 | $29.2M | 3.13% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −171,457−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −73,525−100.0% | Sold out |
| Connacht Asset Management LP | 0 | $0 | 0.00% | −65,065−100.0% | Sold out |
| Avidian Wealth Solutions, LLC | 0 | $0 | 0.00% | −59,000−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −52,952−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −50,015−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −45,933−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −42,400−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −34,008−100.0% | Sold out |
| Cruiser Capital Advisors, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −13,690−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −10,910−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −10,600−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −3,168−100.0% | Sold out |
| Jacobi Capital Management LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Brewin Dolphin Ltd | 0 | $0 | 0.00% | −172−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −156−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Alexandria Capital, LLC | – | – | – | – | Not filed |